Patients with idiopathic pulmonary fibrosis (IPF) want more information from their doctors at diagnosis, according to the results of a new survey. Researchers said that only half of patients surveyed report discussing antifibrotic treatment decisions with their doctors when they’re diagnosed. Results of the survey study, titled “Differences in…
Only Half of IPF Patients Talk to Doctors About Treatments
Treatment with Genentech‘s FDA-approved Esbriet (pirfenidone) has been shown in two independent studies to improve moderate to more severe lung function impairment in patients with idiopathic pulmonary fibrosis (IPF). The results of the studies were recently presented at the American Thoracic Society International Conference (ATS 2017) May 19-24 in Washington,…
Prometic’s PBI-4050 leveled off idiopathic pulmonary fibrosis patients’ decline in lung function, indicating it is a promising treatment for the disease, according to a Phase 2 clinical trial. The leveling occurred when PBI-4050 was used by itself and when it was used in one of two combination therapies. IPF…
The American Lung Association runs a Better Breathers Club for people with chronic lung conditions such as COPD, lung cancer and pulmonary fibrosis. MORE: Seven common questions about Esbriet. The Better Breathers Club…
Bellerophon Therapeutics recently presented promising new data from two Phase 2 clinical trials investigating its product INOpulse in patients with pulmonary hypertension (PH) associated with idiopathic pulmonary fibrosis (IPF), and PH associated with chronic obstructive pulmonary disease (COPD) at the American Thoracic Society 113th International Conference (ATS 2017). The INOpulse device delivers inhaled nitric oxide…
Two weeks ago, I had the joy of sharing my recent trip to our son’s wedding, which was made possible by the generosity of others. During my trip to Houston, I met with a friend of mine who is also a counselor, Jennifer Christian. She interviewed…
Having a service dog can greatly enhance the life of someone living with a chronic disease. They allow patients to regain some of their independence by helping with small everyday tasks like opening and closing doors, fetching meds, acting as a prop or support as their owner stands, switching on lights and attracting attention…
Treatment with Galecto Biotech’s inhaled TD139 may become an effective and safe option for patients with idiopathic pulmonary fibrosis (IPF), according to a clinical trial conducted by Scotland’s University of Edinburgh. Galecto, a Danish pharmaceutical firm, will present the study’s findings at the American Thoracic Society 2017 International Conference…
When a person is diagnosed with pulmonary fibrosis (PF), they may also go through additional tests so doctors can determine the stage of the disease. Staging of pulmonary fibrosis is important to establish the optimal treatment plan and to offer the patient an accurate prognosis. MORE: Eight of the most common lung diseases in women. The…
The Pulmonary Fibrosis Foundation’s (PFF) annual walk is happening in Lincoln Park, Chicago on September 9. While other major cities across the U.S. will be hosting walks, you can still participate even if you can’t make it to any of the listed locations. MORE: Woman with pulmonary fibrosis…
